Legato Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,458
Closed -$435K 624
2024
Q1
$435K Buy
+11,458
New +$435K 0.05% 464